IHM
CYTK icon

Iguana Healthcare Management’s Cytokinetics CYTK Stock Holding History

Iguana Healthcare Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-150,000
Closed -$1.42M – 86
2016
Q2 		$1.42M Sell
150,000
-25,000
-14% -$205K 0.58% 54
2016
Q1 		$1.23M Sell
175,000
-175,000
-50% -$1.28M 0.45% 54
2015
Q4 		$3.66M Buy
+350,000
New +$3.43M 1.2% 23
2014
Q2 		– Sell
-280,000
Closed -$2.66M – 71
2014
Q1 		$2.66M Buy
280,000
+130,000
+87% +$1.18M 1.23% 31
2013
Q4 		$975K Buy
+150,000
New +$985K 0.56% 52

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Iguana Healthcare Management's CYTK Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Cytokinetics (CYTK) in Q3 2016, closing a stake of 150,000 shares — an estimated $1.42M sold.

Iguana Healthcare Management first reported a position in CYTK in Q4 2013 and held it in 5 quarters. The position peaked at $3.66M in Q4 2015. 91 funds tracked by Wall St. Rank hold CYTK as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Cytokinetics position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 150,000 Cytokinetics shares in Q3 2016, an estimated $1.42M.
  • Iguana Healthcare Management first reported a position in Cytokinetics in Q4 2013 and held it in 5 quarters.
  • Iguana Healthcare Management's Cytokinetics position peaked at $3.66M in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.